This paper describes in detail the advances in monoclonal antibodies for radioimmunotherapy since 1990. It introduces the radionuclides, monoclonal antibodies including their dosimetry, toxicity and radiobiological characteristics in radioimmunotherapy. Finally it discusses the problems, potential solutions and future directions in developing monoclonal antibodies for radioimmunotherapy.